Arrowstreet Capital’s Verona Pharma VRNA Stock Holding History

Arrowstreet Capital’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-185,303	Closed	-$19.8M	–	2048
2025 Q3	$19.8M	Buy	+185,303	New	+$19.3M	0.01%	733

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Arrowstreet Capital's VRNA Position: Q4 2025 in Review

Arrowstreet Capital sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 185,303 shares — an estimated $19.8M sold.

Arrowstreet Capital first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $19.8M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Arrowstreet Capital reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Arrowstreet Capital sold 185,303 Verona Pharma shares in Q4 2025, an estimated $19.8M.
Arrowstreet Capital first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Arrowstreet Capital's Verona Pharma position peaked at $19.8M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Arrowstreet Capital's 13F filing for Q4 2025, filed 13 Feb 2026.